P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2023-04, Vol.68, p.S74-S75
Main Authors: Song, R., Lee, D.-E., Lee, S., Kang, H.-S., Han, J.H., Lee, K.S., Sim, S.H., Chae, H., Kwon, Y., Woo, J., Lee, M., Lee, E.-G., Jung, S.-Y.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S75
container_issue
container_start_page S74
container_title Breast (Edinburgh)
container_volume 68
creator Song, R.
Lee, D.-E.
Lee, S.
Kang, H.-S.
Han, J.H.
Lee, K.S.
Sim, S.H.
Chae, H.
Kwon, Y.
Woo, J.
Lee, M.
Lee, E.-G.
Jung, S.-Y.
description
doi_str_mv 10.1016/S0960-9776(23)00268-0
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e429d46e70fc4f48bdbfeab575d9e2af</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960977623002680</els_id><doaj_id>oai_doaj_org_article_e429d46e70fc4f48bdbfeab575d9e2af</doaj_id><sourcerecordid>S0960977623002680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2150-4e722e60b5e71519e976ed9e93ad10da355b6ec265f1843354d04ea3a860aa413</originalsourceid><addsrcrecordid>eNqFkV9rFTEQxYMoeK39CEIeFVk7-bu7TyJt9RYKLW0F30I2O7k3dd0sSapc6Ic3vVf66tPAMOc3M-cQ8o7BJwZMn9xCr6Hp21a_5-IDANddAy_IiinBGwEdvCSr55HX5E3O9wDQC92tyOM1U4zebZEuCcfgSogzjZ5ezS6W3YL07AdNIf-kmxQfFvqQw7yhbgpzcHGxZRunuAmOeutKTJmGmdZuwLlk-ieULV3ffDxZn9_whqJN044OCW0u1NnZYXpLXnk7ZTz-V4_I96_nd6fr5vLq28Xpl8vGcaagkdhyjhoGhW29tse-1TjWIuzIYLRCqUGj41p51kkhlBxBohW202CtZOKIXBy4Y7T3Zknhl007E20w-0ZMG2NTCW5Cg5L3o9TYgnfSy24YB492UK2qC7n1laUOLJdizgn9M4-BeYrD7OMwT14bLsw-DgNV9_mgw_ro74DJZFd9ctX0hK7US8J_CH8BwA6SQg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer</title><source>Open Access: PubMed Central</source><source>ScienceDirect Journals</source><creator>Song, R. ; Lee, D.-E. ; Lee, S. ; Kang, H.-S. ; Han, J.H. ; Lee, K.S. ; Sim, S.H. ; Chae, H. ; Kwon, Y. ; Woo, J. ; Lee, M. ; Lee, E.-G. ; Jung, S.-Y.</creator><creatorcontrib>Song, R. ; Lee, D.-E. ; Lee, S. ; Kang, H.-S. ; Han, J.H. ; Lee, K.S. ; Sim, S.H. ; Chae, H. ; Kwon, Y. ; Woo, J. ; Lee, M. ; Lee, E.-G. ; Jung, S.-Y.</creatorcontrib><identifier>ISSN: 0960-9776</identifier><identifier>EISSN: 1532-3080</identifier><identifier>DOI: 10.1016/S0960-9776(23)00268-0</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Breast (Edinburgh), 2023-04, Vol.68, p.S74-S75</ispartof><rights>2023 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Song, R.</creatorcontrib><creatorcontrib>Lee, D.-E.</creatorcontrib><creatorcontrib>Lee, S.</creatorcontrib><creatorcontrib>Kang, H.-S.</creatorcontrib><creatorcontrib>Han, J.H.</creatorcontrib><creatorcontrib>Lee, K.S.</creatorcontrib><creatorcontrib>Sim, S.H.</creatorcontrib><creatorcontrib>Chae, H.</creatorcontrib><creatorcontrib>Kwon, Y.</creatorcontrib><creatorcontrib>Woo, J.</creatorcontrib><creatorcontrib>Lee, M.</creatorcontrib><creatorcontrib>Lee, E.-G.</creatorcontrib><creatorcontrib>Jung, S.-Y.</creatorcontrib><title>P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer</title><title>Breast (Edinburgh)</title><issn>0960-9776</issn><issn>1532-3080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkV9rFTEQxYMoeK39CEIeFVk7-bu7TyJt9RYKLW0F30I2O7k3dd0sSapc6Ic3vVf66tPAMOc3M-cQ8o7BJwZMn9xCr6Hp21a_5-IDANddAy_IiinBGwEdvCSr55HX5E3O9wDQC92tyOM1U4zebZEuCcfgSogzjZ5ezS6W3YL07AdNIf-kmxQfFvqQw7yhbgpzcHGxZRunuAmOeutKTJmGmdZuwLlk-ieULV3ffDxZn9_whqJN044OCW0u1NnZYXpLXnk7ZTz-V4_I96_nd6fr5vLq28Xpl8vGcaagkdhyjhoGhW29tse-1TjWIuzIYLRCqUGj41p51kkhlBxBohW202CtZOKIXBy4Y7T3Zknhl007E20w-0ZMG2NTCW5Cg5L3o9TYgnfSy24YB492UK2qC7n1laUOLJdizgn9M4-BeYrD7OMwT14bLsw-DgNV9_mgw_ro74DJZFd9ctX0hK7US8J_CH8BwA6SQg</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Song, R.</creator><creator>Lee, D.-E.</creator><creator>Lee, S.</creator><creator>Kang, H.-S.</creator><creator>Han, J.H.</creator><creator>Lee, K.S.</creator><creator>Sim, S.H.</creator><creator>Chae, H.</creator><creator>Kwon, Y.</creator><creator>Woo, J.</creator><creator>Lee, M.</creator><creator>Lee, E.-G.</creator><creator>Jung, S.-Y.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202304</creationdate><title>P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer</title><author>Song, R. ; Lee, D.-E. ; Lee, S. ; Kang, H.-S. ; Han, J.H. ; Lee, K.S. ; Sim, S.H. ; Chae, H. ; Kwon, Y. ; Woo, J. ; Lee, M. ; Lee, E.-G. ; Jung, S.-Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2150-4e722e60b5e71519e976ed9e93ad10da355b6ec265f1843354d04ea3a860aa413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, R.</creatorcontrib><creatorcontrib>Lee, D.-E.</creatorcontrib><creatorcontrib>Lee, S.</creatorcontrib><creatorcontrib>Kang, H.-S.</creatorcontrib><creatorcontrib>Han, J.H.</creatorcontrib><creatorcontrib>Lee, K.S.</creatorcontrib><creatorcontrib>Sim, S.H.</creatorcontrib><creatorcontrib>Chae, H.</creatorcontrib><creatorcontrib>Kwon, Y.</creatorcontrib><creatorcontrib>Woo, J.</creatorcontrib><creatorcontrib>Lee, M.</creatorcontrib><creatorcontrib>Lee, E.-G.</creatorcontrib><creatorcontrib>Jung, S.-Y.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Breast (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, R.</au><au>Lee, D.-E.</au><au>Lee, S.</au><au>Kang, H.-S.</au><au>Han, J.H.</au><au>Lee, K.S.</au><au>Sim, S.H.</au><au>Chae, H.</au><au>Kwon, Y.</au><au>Woo, J.</au><au>Lee, M.</au><au>Lee, E.-G.</au><au>Jung, S.-Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer</atitle><jtitle>Breast (Edinburgh)</jtitle><date>2023-04</date><risdate>2023</risdate><volume>68</volume><spage>S74</spage><epage>S75</epage><pages>S74-S75</pages><issn>0960-9776</issn><eissn>1532-3080</eissn><pub>Elsevier Ltd</pub><doi>10.1016/S0960-9776(23)00268-0</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-9776
ispartof Breast (Edinburgh), 2023-04, Vol.68, p.S74-S75
issn 0960-9776
1532-3080
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e429d46e70fc4f48bdbfeab575d9e2af
source Open Access: PubMed Central; ScienceDirect Journals
title P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A01%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P151%20The%20prediction%20of%20Oncotype%20DX%20risk%20group%20using%20clinicopathologic%20factors%20in%20patients%20with%20HR+/HER2-%20early%20breast%20cancer&rft.jtitle=Breast%20(Edinburgh)&rft.au=Song,%20R.&rft.date=2023-04&rft.volume=68&rft.spage=S74&rft.epage=S75&rft.pages=S74-S75&rft.issn=0960-9776&rft.eissn=1532-3080&rft_id=info:doi/10.1016/S0960-9776(23)00268-0&rft_dat=%3Celsevier_doaj_%3ES0960977623002680%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2150-4e722e60b5e71519e976ed9e93ad10da355b6ec265f1843354d04ea3a860aa413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true